Health Care Without Harm aims to transform global healthcare to minimize its environmental impact and promote sustainability. Lorna Rothery spoke to the team about the effects of pharmaceutical pollution and the necessity for the industry to adopt greener practices.
Roxane Feller, AnimalhealthEurope Secretary-General, tells us all about the new EU rules on veterinary medicines to support more responsible use of antibiotics.
The U.S. Food and Drug Administration (FDA) has given authorisation for the Pfizer/BioNTech COVID-19 booster vaccine to be administered to people aged 65 and over.
Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, explains why drug-candidate ABX464 has the potential to address the urgent need for new, safe short- and long-term effective drugs to treat Inflammatory Bowel Diseases.
Lauren Matelski, Jeremy MacMahon, and Pamela J. Lein from the University of California, Davis, weigh the risks associated with COVID-19 vaccines versus the benefits.
Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explains how glycoscience offers opportunities galore in healthcare.
Five new COVID-19 research projects will study the durability of vaccine responses, low responses linked with health conditions and the effect of booster shots.
The UK Government has signed a contract for 35 million more doses of the Pfizer/BioNTech COVID-19 vaccine, to be delivered from the second half of 2022..
Rick Clayton, Technical Director, AnimalhealthEurope, in the final chapter of this three-part series, examines the benefits of benchmarking regulatory systems and promoting Good Regulatory Practice.
